Schedule 13G ownership disclosure

Sarepta Therapeutics Inc

Security class unavailable · CUSIP: 803607100

Event date: 2021-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,024,130
Percent of class
10.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422848-21-000005
Form type
SC 13G/A
Filer
Capital Research Global Investors
CIK
CIK 1422848
Filed
Feb 10, 2021
Reporting period
Jan 29, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub